Taiwan FDA registration 40908ad7d802534b1bc67564ba1481b0
Rate's comprehensive blood glucose management system
TW: 瑞特全方位血糖管理系統
Registration details
- Analysis ID
- 40908ad7d802534b1bc67564ba1481b0
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Daqing Factory of Huaguang Biotechnology Co., Ltd
Product details
- Intended Use
- Rateter Total Blood Glucose Management System is a browser-based blood glucose data management software designed to provide professionals in healthcare institutions with an overview of glucose measurement data collected by a continuous glucose monitoring system (CGM) and easy analysis to produce relevant charts. Healthcare organizations can also use this system to record other biochemical measurement data of patients, which is conducive to the comprehensive management of all information related to blood glucose control and diabetes.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1350 Continuous Blood Glucose Monitoring System Secondary Display
- Import Information
- 國產;; QMS/QSD
Dates and status
- Registration Date
- Jun 24, 2024
- Expiry Date
- Jun 24, 2029
About this record
Access comprehensive regulatory information for Rate's comprehensive blood glucose management system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 40908ad7d802534b1bc67564ba1481b0 and manufactured by Daqing Factory of Huaguang Biotechnology Co., Ltd. The authorized representative in Taiwan is Daqing Factory of Huaguang Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices